Frequently asked questions
Frequently asked questions on GHK-Cu research and safety
Direct answers grounded in the nineteen peer-reviewed papers in our bibliography.
Questions on GHK-Cu safety and legal status
Is copper peptide safe on human skin?
Published human safety data is limited to small topical studies with distinct endpoints. In the 2016 six-month trial in 45 men, a topical combination of 5-aminolevulinic acid and GHK peptide (ALAVAX) reported no adverse events in any group. In the 2006 carbon dioxide laser resurfacing trial in 13 patients, patient satisfaction was higher in the topical GHK-Cu group than in the control group, with no statistically significant objective difference in erythema, while Pickart et al. 2015 summarizes small cosmetic facial cream studies. By contrast, injectable GHK-Cu has zero human clinical safety trials, and its systemic clearance and theoretical copper-loading risks in people remain untested.
Is GHK-Cu approved by the FDA for medical use?
No. The United States Food and Drug Administration has never approved GHK-Cu as a drug to diagnose, treat, cure, or prevent any disease. Copper Tripeptide-1 is a legal cosmetic ingredient in topical skin care.
What is Copper Tripeptide-1 on a skin cream label?
Copper Tripeptide-1 is the International Nomenclature of Cosmetic Ingredients term for GHK-Cu, indicating that the glycyl-L-histidyl-L-lysine peptide is pre-bound to divalent copper in a 1:1 ratio (Pickart et al. 2015).
Questions on GHK-Cu mechanism and skin interactions
How does bare GHK differ from GHK-Cu in studies?
Bare GHK is the three-amino-acid chain glycyl-L-histidyl-L-lysine without a metal ion. GHK-Cu is that same tripeptide chelating one divalent copper ion in a 1:1 complex (Pickart 2008). In the 2000 Simeon fibroblast study, copper-bound GHK-Cu stimulated matrix metalloproteinase-2 expression, whereas bare GHK without copper failed to trigger the response.
Why is GHK-Cu blue-violet in water?
In aqueous solution near pH 5 to 6.5 at a 1:1 copper-to-peptide ratio, the blue-violet color reflects the expected Cu(II) d-orbital absorption of an intact GHK-Cu complex (Pickart 2008). A color shift toward brown or green indicates oxidation or precipitation of the complex (Mortazavi et al. 2025).
How does GHK-Cu interact with vitamin C on skin?
Strong reducing agents such as low-pH L-ascorbic acid (below roughly pH 3.5) can reduce Cu(II) and disrupt the complex, while alpha- or beta-hydroxy acids and other low-pH actives can destabilize the GHK-Cu complex or compete for copper (Mortazavi et al. 2025).
Questions on GHK-Cu gene data and animal blood studies
What did the 2018 GHK-Cu gene study test?
No living person had their genes tested in that paper. The 2018 Pickart and Margolina study analyzed Broad Institute Connectivity Map cell-culture data and reported that approximately 31.2% of human genes changed at a threshold of at least 50%, with about 2,100 genes meeting that threshold (59% up and 41% down); the approximately 4,000 gene figure is an extrapolation.
What happens to GHK in rat blood studies?
In the 1997 Endo et al. rat chromatography study, intravenous GHK was rapidly cleaved by plasma enzymes into the dipeptide L-histidyl-L-lysine, with detection limits of 50 nanograms per milliliter for GHK and 15 nanograms per milliliter for histidyl-lysine. I regard Endo's GHK chromatography paper as a reality check on injectable claims because free GHK broke down rapidly in rat plasma. For full citations on every paper mentioned here, visit the references page.